The aryl hydrocarbon receptor: Fine-tuning the immune-response

Current Opinion in Immunology

Volumn 22, Issue 6, 2010, Pages 747-752

  Veldhoen, Marc ^a   Duarte, João H ^b  

^a BABRAHAM INSTITUTE   (United Kingdom)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AROMATIC HYDROCARBON; AROMATIC HYDROCARBON RECEPTOR; CRYOPYRIN; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17;

ADAPTIVE IMMUNITY; AUTOIMMUNITY; BINDING AFFINITY; CYTOKINE RELEASE; DISEASE PREDISPOSITION; GENE EXPRESSION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; IMMUNOMODULATION; IMMUNOPATHOLOGY; IMMUNOREGULATION; IMMUNOSTIMULATION; INNATE IMMUNITY; LIGAND BINDING; NONHUMAN; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TRANSPORT; REGULATORY T LYMPHOCYTE; REVIEW; TH1 CELL; TH17 CELL;

ANIMALS; AUTOIMMUNE DISEASES; HUMANS; RECEPTORS, ARYL HYDROCARBON;

EID: 78649808714     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2010.09.001     Document Type: Review

References (50)

1. Cadwell K., Patel K.K., Maloney N.S., Liu T.C., Ng A.C., Storer C.E., Head R.D., Xavier R., Stappenbeck T.S., Virgin H.W. Virus-plus-susceptibility gene interaction determines Crohn's disease gene Atg16L1 phenotypes in intestine. Cell 2010, 141:1135-1145.
2. Gu Y.Z., Hogenesch J.B., Bradfield C.A. The PAS superfamily: sensors of environmental and developmental signals. Annu Rev Pharmacol Toxicol 2000, 40:519-561.
3. Weidemann A., Johnson R.S. Biology of HIF-1alpha. Cell Death Differ 2008, 15:621-627.
4. Boutros P.C., Moffat I.D., Franc M.A., Tijet N., Tuomisto J., Pohjanvirta R., Okey A.B. Dioxin-responsive AHRE-II gene battery: identification by phylogenetic footprinting. Biochem Biophys Res Commun 2004, 321:707-715.
5. Kay S.A. PAS, present, and future: clues to the origins of circadian clocks. Science 1997, 276:753-754.
6. Hahn M.E., Karchner S.I., Evans B.R., Franks D.G., Merson R.R., Lapseritis J.M. Unexpected diversity of aryl hydrocarbon receptors in non-mammalian vertebrates: insights from comparative genomics. J Exp Zool A Comp Exp Biol 2006, 305:693-706.
7. Denison M.S., Nagy S.R. Activation of the aryl hydrocarbon receptor by structurally diverse exogenous and endogenous chemicals. Annu Rev Pharmacol Toxicol 2003, 43:309-334.
8. Oberg M., Bergander L., Hakansson H., Rannug U., Rannug A. Identification of the tryptophan photoproduct 6-formylindolo[3,2-b]carbazole, in cell culture medium, as a factor that controls the background aryl hydrocarbon receptor activity. Toxicol Sci 2005, 85:935-943.
9. Paigen B., Ward E., Reilly A., Houten L., Gurtoo H.L., Minowada J., Steenland K., Havens M.B., Sartori P. Seasonal variation of aryl hydrocarbon hydroxylase activity in human lymphocytes. Cancer Res 1981, 41:2757-2761.
10. Veldhoen M., Hirota K., Christensen J., O'Garra A., Stockinger B. Natural agonists for aryl hydrocarbon receptor in culture medium are essential for optimal differentiation of Th17 T cells. J Exp Med 2009, 206:43-49.
11. Perdew G.H., Babbs C.F. Production of Ah receptor ligands in rat fecal suspensions containing tryptophan or indole-3-carbinol. Nutr Cancer 1991, 16:209-218.
12. Frericks M., Meissner M., Esser C. Microarray analysis of the AHR system: tissue-specific flexibility in signal and target genes. Toxicol Appl Pharmacol 2007, 220:320-332.
13. Dalton T.P., Puga A., Shertzer H.G. Induction of cellular oxidative stress by aryl hydrocarbon receptor activation. Chem Biol Interact 2002, 141:77-95.
14. Bankoti J., Burnett A., Navarro S., Miller A.K., Rase B., Shepherd D.M. Effects of TCDD on the fate of naive dendritic cells. Toxicol Sci 2010, 115:422-434.
15. Jux B., Kadow S., Esser C. Langerhans cell maturation and contact hypersensitivity are impaired in aryl hydrocarbon receptor-null mice. J Immunol 2009, 182:6709-6717.
16. Nebert D.W., Karp C.L. Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology. J Biol Chem 2008, 283:36061-36065.
17. Kimura A., Naka T., Nakahama T., Chinen I., Masuda K., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses. J Exp Med 2009, 206:2027-2035.
18. Martinon F. Signaling by ROS drives inflammasome activation. Eur J Immunol 2010, 40:616-619.
19. Meng G., Zhang F., Fuss I., Kitani A., Strober W. A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity 2009, 30:860-874.
20. Iyer S.S., Accardi C.J., Ziegler T.R., Blanco R.A., Ritzenthaler J.D., Rojas M., Roman J., Jones D.P. Cysteine redox potential determines pro-inflammatory IL-1beta levels. PLoS One 2009, 4:e5017.
21. Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van Loo G., Ermolaeva M., Veldhuizen R., Leung Y.H., Wang H., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 2008, 133:235-249.
22. Kobayashi S., Okamoto H., Iwamoto T., Toyama Y., Tomatsu T., Yamanaka H., Momohara S. A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis. Rheumatology (Oxford) 2008, 47:1317-1322.
23. Besteman E.G., Zimmerman K.L., Holladay S.D. Tetrachlorodibenzo-p-Dioxin (TCDD) inhibits differentiation and increases apoptotic cell death of precursor T-cells in the fetal mouse thymus. J Immunotoxicol 2005, 2:107-114.
24. Camacho I.A., Nagarkatti M., Nagarkatti P.S. Evidence for induction of apoptosis in T cells from murine fetal thymus following perinatal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Toxicol Sci 2004, 78:96-106.
25. Gill B.C., Jeon C.H., Sung H.N., Kim H.L., Jin D.W., Park J.H. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates the expression of cKrox and Runx3, transcription regulatory factors controlling the lineage commitment of CD4+CD8+ into CD4 and CD8 thymocytes, respectively. Toxicol Lett 2008, 180:189-195.
26. Esser C., Rannug A., Stockinger B. The aryl hydrocarbon receptor in immunity. Trends Immunol 2009, 30:447-454.
27. Negishi T., Kato Y., Ooneda O., Mimura J., Takada T., Mochizuki H., Yamamoto M., Fujii-Kuriyama Y., Furusako S. Effects of aryl hydrocarbon receptor signaling on the modulation of TH1/TH2 balance. J Immunol 2005, 175:7348-7356.
28. Hirota K., Martin B., Veldhoen M. Development, regulation and functional capacities of Th17 cells. Semin Immunopathol 2010, 32:3-16.
29. Veldhoen M., Hirota K., Westendorf A.M., Buer J., Dumoutier L., Renauld J.C., Stockinger B. The aryl hydrocarbon receptor links TH17-cell-mediated autoimmunity to environmental toxins. Nature 2008, 453:106-109.
30. Kimura A., Naka T., Nohara K., Fujii-Kuriyama Y., Kishimoto T. Aryl hydrocarbon receptor regulates Stat1 activation and participates in the development of Th17 cells. Proc Natl Acad Sci USA 2008, 105:9721-9726.
31. Quintana F.J., Basso A.S., Iglesias A.H., Korn T., Farez M.F., Bettelli E., Caccamo M., Oukka M., Weiner H.L. Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor. Nature 2008, 453:65-71.
32. Martin B., Hirota K., Cua D.J., Stockinger B., Veldhoen M. Interleukin-17-producing gammadelta T cells selectively expand in response to pathogen products and environmental signals. Immunity 2009, 31:321-330.
33. Kerkvliet N.I., Steppan L.B., Vorachek W., Oda S., Farrer D., Wong C.P., Pham D., Mourich D.V. Activation of aryl hydrocarbon receptor by TCDD prevents diabetes in NOD mice and increases Foxp3 T cells in pancreatic lymph nodes. Immunotherapy 2009, 1:539-547.
34. Funatake C.J., Ao K., Suzuki T., Murai H., Yamamoto M., Fujii-Kuriyama Y., Kerkvliet N.I., Nohara K. Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response. J Immunotoxicol 2009, 6:194-203.
35. Nohara K., Suzuki T., Ao K., Murai H., Miyamoto Y., Inouye K., Pan X., Motohashi H., Fujii-Kuriyama Y., Yamamoto M., et al. Constitutively active aryl hydrocarbon receptor expressed in T cells increases immunization-induced IFN-gamma production in mice but does not suppress T(h)2-cytokine production or antibody production. Int Immunol 2009, 21:769-777.
36. Gandhi R., Kumar D., Burns E.J., Nadeau M., Dake B., Laroni E., Kozoriz D., Weiner H.L., Quintana F.J. AHR activation induces human Tr1-like and Foxp3+ Treg cells. Nat. Immunol. 2010, 9:846-853.
37. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10:170-181.
38. Guarda G., Dostert C., Staehli F., Cabalzar K., Castillo R., Tardivel A., Schneider P., Tschopp J. T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature 2009, 460:269-273.
39. Saraiva M., Christensen J.R., Veldhoen M., Murphy T.L., Murphy K.M., O'Garra A. Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose. Immunity 2009, 31:209-219.
40. Zenewicz L.A., Yancopoulos G.D., Valenzuela D.M., Murphy A.J., Stevens S., Flavell R.A. Innate and adaptive interleukin-22 protects mice from inflammatory bowel disease. Immunity 2008, 29:947-957.
41. Apetoh L., Quintana F.J., Pot C., Joller N., Xiao S., Kumar D., Burns E.J., Sherr D.H., Weiner L.H., Kuchroo V.K. The Aryl hydrocarbon Receptor (AhR) interacts with c-Maf to promote the differentiation of IL-27-induced regulatory type 1 (TR1) cells. Nat Immunol 2010, 9:854-861.
42. Haringer B., Lozza L., Steckel B., Geginat J. Identification and characterization of IL-10/IFN-gamma-producing effector-like T cells with regulatory function in human blood. J Exp Med 2009, 206:1009-1017.
43. Koch M.A., Tucker-Heard G., Perdue N.R., Killebrew J.R., Urdahl K.B., Campbell D.J. The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation. Nat Immunol 2009, 10:595-602.
44. Zheng Y., Chaudhry A., Kas A., deRoos P., Kim J.M., Chu T.T., Corcoran L., Treuting P., Klein U., Rudensky A.Y. Regulatory T-cell suppressor program co-opts transription factor IRF4 to control T(H)2 responses. Nature 2009, 458:351-356.
45. Sekine H., Mimura J., Oshima M., Okawa H., Kanno J., Igarashi K., Gonzalez F.J., Ikuta T., Kawajiri K., Fujii-Kuriyama Y. Hypersensitivity of aryl hydrocarbon receptor-deficient mice to lipopolysaccharide-induced septic shock. Mol Cell Biol 2009, 29:6391-6400.
46. Head J.L., Lawrence B.P. The aryl hydrocarbon receptor is a modulator of anti-viral immunity. Biochem Pharmacol 2009, 77:642-653.
47. Hirota K, Duarte JH, Veldhoen M, Hornsby E, Li Y, Wilhelm C, Tolaini M, Menzel U, Garefalaki A, Vassilakos D, et al: Fate mapping of interleukin-17 producing T cells in inflammatory responses. Submitted for publication.
48. Veldhoen M. Detoxifying immune-responses with help of a toxin-receptor. Nat Immunol 2010, 11(9):779-781.
49. Takatori H., Kanno Y., Watford W.T., Tato C.M., Weiss G., Ivanov I.I., Littman D.R., O'Shea J.J. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. J Exp Med 2009, 206:35-41.
50. Hughes T., Becknell B., Freud A.G., McClory S., Briercheck E., Yu J., Mao C., Giovenzana C., Nuovo G., Wei L., et al. Interleukin-1beta selectively expands and sustains interleukin-22+ immature human natural killer cells in secondary lymphoid tissue. Immunity 2010, 32:803-814.